VanEck Biotech ETF
BBH
115 hedge funds and large institutions have $150M invested in VanEck Biotech ETF in 2024 Q4 according to their latest regulatory filings, with 16 funds opening new positions, 24 increasing their positions, 32 reducing their positions, and 13 closing their positions.
23% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 13
0% more funds holding
Funds holding: 115 → 115 (0)
1% less capital invested
Capital invested by funds: $152M → $150M (-$1.49M)
25% less repeat investments, than reductions
Existing positions increased: 24 | Existing positions reduced: 32
40.53% less ownership
Funds ownership: 78.34% → 37.81% (-41%)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
TWC
TD Waterhouse Canada
Toronto,
Ontario, Canada
|
+$10.7M |
| 2 |
Bank of America
Charlotte,
North Carolina
|
+$6.74M |
| 3 |
Morgan Stanley
New York
|
+$3.25M |
| 4 |
ACA
Atlas Capital Advisors
Jackson,
Wyoming
|
+$959K |
| 5 |
TAM
Tocqueville Asset Management
New York
|
+$922K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$2.7M |
| 2 |
GT
Glenview Trust
Louisville,
Kentucky
|
-$1.65M |
| 3 |
Jane Street
New York
|
-$1.48M |
| 4 |
MIM
Miller Investment Management
West Conshohocken,
Pennsylvania
|
-$1.28M |
| 5 |
Northwestern Mutual Wealth Management
Milwaukee,
Wisconsin
|
-$662K |
BBH Hedge Fund Activity: Q4 2024 in Review
115 of the 7,592 institutional investors tracked by Wall St. Rank reported a position in VanEck Biotech ETF (BBH) for Q4 2024, worth a combined $150M — down 0.98% from $152M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new BBH positions and 13 closed out — a net gain of 3 holders — while 24 added to existing stakes and 32 trimmed.
The largest buyer was TD Waterhouse Canada, opening a new position worth an estimated $10.7M. The largest seller was Citadel Advisors, cutting an estimated $2.7M.
- 115 institutional investors held VanEck Biotech ETF (BBH) as of Q4 2024, unchanged from Q3 2024.
- Funds reported $150M of VanEck Biotech ETF stock for Q4 2024, down 0.98% quarter-over-quarter.
- 16 funds opened new VanEck Biotech ETF positions in Q4 2024 and 13 closed out, a net change of +3 holders.
- The largest VanEck Biotech ETF buyer in Q4 2024 was TD Waterhouse Canada, an estimated $10.7M added.
- The largest VanEck Biotech ETF seller in Q4 2024 was Citadel Advisors, an estimated $2.7M sold.
Based on aggregated 13F filings for Q4 2024.